Tag: Immunomic Therapeutics


AsclepiX’s Wendy Perrow and Glyscend Among 2017 ICE Winners

AsclepiX’s Wendy Perrow and Glyscend Among 2017 ICE Winners

TEDCO has announced its 2017 ICE award recipients, and two of the six winners have connections to Johns Hopkins. On May 25, AsclepiX CEO Wendy Perrow was named entrepreneur of the year, and Glyscend received an award for innovation.

Perrow began leading the FastForward startup, a therapeutics company based on technology developed by Johns Hopkins Drs. Jordan Green and Aleksander Popel, in the summer of 2016 and currently manages the company’s business, clinical, financial, licensing and corporate development efforts. Prior to AsclepiX, Perrow served as CEO of Alba Therapeutics.

Glyscend’s ICE award marks the second time the company’s non-invasive treatment for type 2 diabetes has received recognition for innovation in the past six months. Glyscend also won Johnson & Johnson Innovation’s World Without Disease Quickfire Challenge, a national competition that awarded them $500,000.

TEDCO created the ICE Awards to honor innovation, corporate excellence and entrepreneurship at its coolest portfolio companies and to recognize the best and brightest entrepreneurs developing cutting-edge technologies and enriching Maryland.

This is the second straight strong showing by Johns Hopkins-backed startups. Sisu Global Health, a startup developing medical devices for emerging markets, won in the innovation category last year. Additionally, Immunomic Therapeutics, a biotechnology company developing an immunomodulation platform that has the platform to transform the allergy and cancer immunotherapy markets, won for corporate excellence.

Interested in investing in a venture? Click here!


WP-Backgrounds Lite by InoPlugs Web Design and Juwelier Schönmann 1010 Wien